Dietary Supplements; Endometrial Hyperplasia/prevention & control; Estrogen Replacement Therapy; Estrogens, Conjugated (USP)/therapeutic use; Genistein/therapeutic use; Glucose Intolerance/prevention & control; Phytoestrogens/therapeutic use; Adiposity/drug effects; Animals; Diet, High-Fat/adverse effects; Dietary Supplements/adverse effects; Endometrial Hyperplasia/chemically induced; Endometrial Hyperplasia/metabolism; Endometrial Hyperplasia/pathology; Endometrium/drug effects; Endometrium/metabolism; Endometrium/pathology; Estrogen Replacement Therapy/adverse effects; Estrogens/adverse effects; Estrogens/therapeutic use; Estrogens, Conjugated (USP)/adverse effects; Female; Genistein/administration & dosage; Genistein/adverse effects; Glucose Intolerance/chemically induced; Glucose Intolerance/metabolism; Glucose Intolerance/pathology; Liver/drug effects; Liver/metabolism; Liver/pathology; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease/chemically induced; Non-alcoholic Fatty Liver Disease/metabolism; Non-alcoholic Fatty Liver Disease/pathology; Non-alcoholic Fatty Liver Disease/prevention & control; Ovariectomy/adverse effects; Overweight/etiology; Overweight/metabolism; Overweight/pathology; Overweight/prevention & control; Phytoestrogens/administration & dosage; Phytoestrogens/adverse effects; Raloxifene Hydrochloride/adverse effects; Raloxifene Hydrochloride/therapeutic use; Random Allocation; Selective Estrogen Receptor Modulators/adverse effects; Selective Estrogen Receptor Modulators/therapeutic use